You are here: Industry Insights > Bharat Biotech

News List

Bharat Biotech signs supply deal with Brazil for 20 million doses of COVAXIN expresspharma
March 01, 2021
Bharat Biotech International confirmed that the company has signed an agreement with Brazil for supply of 20 million doses of COVAXIN.
Ukraine delegation visit Bharat Biotech’s vaccine facility, discuss supplies of COVAXIN to Ukraine expresspharma
February 25, 2021
Led by Dr Maksym Stepanov, Minister of Health, Ukraine, the delegation also included Igor Ivashchenko, Deputy Minister of Health, Ukraine, and Ivan Konovalov, Head of Trade and Economic Dept, Embassy of Ukraine in India.
Bharat Biotech seeks approval for COVID-19 vaccine in over 40 countries expresspharma
February 20, 2021
Pricing of COVAXIN for international markets will be based upon supply timelines, purchase commitments and procurement volumes, informed the company.
Bharat Biotech’s Covaxin may provide Covid-19 immunity for 12 months pharmaceutical-technology
February 18, 2021
All India Institute of Medical Sciences (AIIMS) said that Bharat Biotech’s Covid-19 vaccine, Covaxin, may provide immunity against the disease for nine to 12 months, as per the mathematical calculations.
India orders 14.5 mn more COVID-19 vaccine doses from SII and Bharat Biotech expresspharma
February 10, 2021
India has ordered 10 million more doses of the AstraZeneca COVID-19 vaccine from the (SII) and 4.5 million more of a homegrown one from Bharat Biotech, company representatives told Reuters.
Ocugen, Bharat Biotech announce agreement for commercialisation of Covaxin in US market expresspharma
February 03, 2021
Ocugen is also in active discussions with manufacturers in the US to produce a significant number of doses of COVAXIN to support its US immunisation programme.
SII, Bharat Biotech welcome enhanced focus on health, immunisation in budget expresspharma
February 02, 2021
Government has increased allocation for the healthcare sector and alloted Rs 35,000 crore towards COVID-19 vaccination in 2021-22 fiscal.
CDSCO’s expert panel recommends approval for phase 1 trial of Bharat Biotech’s nasal vaccine for COVID-19 expresspharma
January 21, 2021
An intranasal vaccine will not only be simple to administer but reduce the use of medical consumables such as needles, syringes.
Bharat Biotech gets Letter of Comfort for 45 lakh doses of Covaxin expresspharma
January 20, 2021
Bharat Biotech has received a fresh Letter of Comfort from Government of India for another 45 lakh doses of its COVID-19 vaccine, Covaxin, informed sources.
Bharat Biotech factsheet advises people with allergies, medical conditions to not take Covaxin expresspharma
January 19, 2021
The list also includes pregnant or breastfeeding women, and people who have received another COVID-19 vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page